Show
Sort by
-
Evaluation of a Cerebral-Blood-Volume (CBV) pharmaco-MRI (phMRI) assay utilizing low (0.1mg/70kg) and high (0.2mg/70kg) dose buprenorphine infusion and a novel USPIO contrast agent (Ferumoxytol) in healthy human subjects
-
Farmacotherapeutische actualiteit
-
Barriers to discontinuation of chronic benzodiazepine use in nursing home residents: perceptions of general practitioners and nurses
-
Self-medication of headache : identification of subgroups of patients through cluster analysis
-
- Journal Article
- A1
- open access
Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study
-
Quality of prescribing in Belgian nursing homes: an electronic assessment of the medication chart
-
A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application
-
Operational rules for the implementation of INN prescribing
-
Propionyl-L-carnitine for intermittent claudication: a cochrane review
-
Investigation of combined CYP3A4 inductive/inhibitory properties by studying statin interactions: a model study with the renin inhibitor ACT-178882